How Will a Treatable Traits Approach Reshape Clinical Practice in Chronic Cough?

IF 4.1 2区 医学 Q2 ALLERGY
Yeonhee Kim, Surinder S Birring, Lorcan McGarvey, Alyn H Morice, Woo-Jung Song
{"title":"How Will a Treatable Traits Approach Reshape Clinical Practice in Chronic Cough?","authors":"Yeonhee Kim, Surinder S Birring, Lorcan McGarvey, Alyn H Morice, Woo-Jung Song","doi":"10.4168/aair.2025.17.3.304","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic cough, which affects 5%-18% of adults, has traditionally been considered a symptom defined by its duration. However, recent advances in understanding the pathophysiology of chronic cough have prompted the concept that chronic cough may exist as a distinct clinical entity driven by neuronal dysregulation and cough hypersensitivity. This evolving perspective recognizes various treatable traits and clinical characteristics which support the notion of cough as a disease entity and beyond that of a symptom-based classification. Initially developed for asthma and chronic obstructive pulmonary disease, the treatable traits approach has now been extended to chronic cough management, offering a more personalized treatment model. It focuses on identifying modifiable traits that significantly impact patient outcomes. However, challenges remain in implementing this model, including the need for trait validation, biomarker development, staff training, and the integration of new therapies. Despite these challenges, the treatable traits approach provides a promising framework for refining chronic cough management strategies and improving patient care.</p>","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"17 3","pages":"304-316"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12117485/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2025.17.3.304","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic cough, which affects 5%-18% of adults, has traditionally been considered a symptom defined by its duration. However, recent advances in understanding the pathophysiology of chronic cough have prompted the concept that chronic cough may exist as a distinct clinical entity driven by neuronal dysregulation and cough hypersensitivity. This evolving perspective recognizes various treatable traits and clinical characteristics which support the notion of cough as a disease entity and beyond that of a symptom-based classification. Initially developed for asthma and chronic obstructive pulmonary disease, the treatable traits approach has now been extended to chronic cough management, offering a more personalized treatment model. It focuses on identifying modifiable traits that significantly impact patient outcomes. However, challenges remain in implementing this model, including the need for trait validation, biomarker development, staff training, and the integration of new therapies. Despite these challenges, the treatable traits approach provides a promising framework for refining chronic cough management strategies and improving patient care.

可治疗的特征方法将如何重塑慢性咳嗽的临床实践?
慢性咳嗽影响了5%-18%的成年人,传统上被认为是一种由持续时间定义的症状。然而,最近对慢性咳嗽病理生理的研究进展提示,慢性咳嗽可能是由神经元失调和咳嗽过敏驱动的一种独特的临床实体。这种不断发展的观点认识到各种可治疗的特征和临床特征,这些特征支持咳嗽作为一种疾病实体的概念,而不仅仅是基于症状的分类。最初开发用于哮喘和慢性阻塞性肺疾病,可治疗特征方法现已扩展到慢性咳嗽管理,提供更个性化的治疗模式。它侧重于识别显著影响患者预后的可改变特征。然而,实施这一模式仍然存在挑战,包括需要性状验证、生物标志物开发、员工培训和新疗法的整合。尽管存在这些挑战,可治疗特征方法为完善慢性咳嗽管理策略和改善患者护理提供了一个有希望的框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
6.80%
发文量
53
审稿时长
>12 weeks
期刊介绍: The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信